EBERCONAZOLE 1%w/w IP

A topical antimycotic preparation that treats fungal infections of the skin such as dermatophytoses, candidiasis, and pityriasis. (Trinidad Repiso Montero, 2006) An imidazole antifungal with a broad spectrum of activity that is effective against a wide range of yeast and fungi such as dermatophytes, candidiasis, yeasts (Malassezzia furfur), and Pityriasis versicolor. (Latha Subramanya Moodahadu, 2014) A valuable therapeutic medicine against a wide range of dermatophyte species than the other topical agents. (Latha Subramanya Moodahadu, 2014) An effective therapy for fungal infections produced by dermatophytes, with good safety and tolerability profile. (Trinidad Repiso Montero, 2006) More effective than clotrimazole against dermatophytosis with an overall efficacy of 72% for eberconazole and 61% for clotrimazole. (A del Palacio, 2001) An appropriate alternative for the treatment of dermatophytoses. (Trinidad Repiso Montero, 2006) A new addition in the armamentarium for the treatment of tinea versicolor. A better option than sertaconazole 2% cream and luliconazole 1% cream in relieving symptoms like pruritus and scaling in dermatophytosis patients. (Annie Ratnam Nakka, 2020) A safe and effective treatment option in the management of Tinea corporis and cruris in Indian patients. (Jayakar Thomas, 2021)